15.6% Below Target

Merck & Co., Inc. (MRK) has a consensus 12-month price target of $131.58, implying 15.6% upside from $113.87. The 37 analysts covering MRK see moderate appreciation potential.

MRK has a consensus rating of "Buy" based on 37 Wall Street analysts. The rating breakdown is predominantly bullish, with 25 Buy/Strong Buy ratings. The consensus 12-month price target of $131.58 implies 15.6% upside from current levels.

MRK trades at a forward P/E of 22.1589x, representing a moderate valuation. With analysts targeting $131.58 (15.6% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $150 for MRK, while the most conservative target is $100. The consensus of $131.58 represents the median expectation. Our quantitative valuation model projects a bull case target of $170 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

MRK is heavily covered by Wall Street, with 37 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 25 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month MRK stock forecast based on 37 Wall Street analysts shows a consensus price target of $131.58, with estimates ranging from $100 (bear case) to $150 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $129, with bear/bull scenarios of $81/$170.

Our quantitative valuation model calculates MRK's fair value at $129 (base case), with a bear case of $81 and bull case of $170. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.

MRK trades at a forward P/E ratio of 22.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 15.6x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on MRK, with a "Buy" consensus rating and $131.58 price target (15.6% upside). 25 of 37 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

MRK analyst price targets range from $100 to $150, a 38% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $131.58 consensus represents the middle ground. Our model's $81-$170 range provides an independent fundamental perspective.